179 related articles for article (PubMed ID: 21617199)
1. Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.
Hock BD; Mackenzie KA; Cross NB; Taylor KG; Currie MJ; Robinson BA; Simcock JW; McKenzie JL
Nephrol Dial Transplant; 2012 Jan; 27(1):402-10. PubMed ID: 21617199
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study.
Hock BD; McKenzie JL; Cross NB; Currie MJ
Transpl Immunol; 2015 Jun; 32(3):164-71. PubMed ID: 25968653
[TBL] [Abstract][Full Text] [Related]
3. Quantification of plasmacytoid dendritic cells and type 1 myeloid dendritic cells in peripheral blood of renal transplant recipients with and without squamous cell carcinoma.
Sandvik LF; Vogelsang P; Leivestad T; Jonsson R; Appel S
Acta Derm Venereol; 2012 Nov; 92(6):623-4. PubMed ID: 22378032
[No Abstract] [Full Text] [Related]
4. Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.
Poschke I; Mao Y; Adamson L; Salazar-Onfray F; Masucci G; Kiessling R
Cancer Immunol Immunother; 2012 Jun; 61(6):827-38. PubMed ID: 22080405
[TBL] [Abstract][Full Text] [Related]
5. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients.
Lim WH; Kireta S; Thomson AW; Russ GR; Coates PT
Transplantation; 2006 Jan; 81(2):160-8. PubMed ID: 16436957
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
7. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and staging of chronic kidney disease in renal transplant recipients.
Costa de Oliveira CM; Mota MU; Mota RS; Nóbrega JO; Melo DS; Vieira AS; Fernandes PF; Campos Hde H; Evangelista JB
Clin Transplant; 2009; 23(5):628-36. PubMed ID: 19563484
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
[TBL] [Abstract][Full Text] [Related]
11. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
Dziunycz P; Hofbauer GF
Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
[TBL] [Abstract][Full Text] [Related]
12. Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients.
Krynitz B; Lundh Rozell B; Lindelöf B
Acta Derm Venereol; 2010 Jul; 90(4):379-85. PubMed ID: 20574603
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls.
Sandvik LF; Skarstein K; Krynitz B; Volchenkov R; Sviland L; Leivestad T; Jonsson R; Appel S
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2128-35. PubMed ID: 25845701
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL
Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618
[TBL] [Abstract][Full Text] [Related]
15. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma.
Moloney FJ; Kelly PO; Kay EW; Conlon P; Murphy GM
Dermatol Surg; 2004 Apr; 30(4 Pt 2):674-8. PubMed ID: 15061854
[TBL] [Abstract][Full Text] [Related]
16. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
[TBL] [Abstract][Full Text] [Related]
17. [Myeloid-derived suppressor cells in patients with breast cancer].
Gonda K; Shibata M; Ohtake T; Yasuda M; Abe N; Watanabe K; Ando J; Okano M; Onozawa H; Tachibana K; Ohto H; Takenoshita S
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1363-8. PubMed ID: 22996770
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
20. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]